Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in France

Inclusion Criteria

• •Registry
• •* Patient ≥ 18 years old
• •* Patient with T2D
• •Ambispective Cohort
• •* Patient ≥ 18 years old
• •* Patient with T2D
• •* Patient initiated with Saxagliptin in the last 6 months before the inclusion or day of inclusion visit (whatever his/her ongoing hypoglycaemic treatment)
• •* Patient agreeing to participate, and not yet enrolled by another physician